Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Concord Acquisition CorpCND · Entity 124511 | Director | December 07, 2020 | December 08, 2020 |
| Concord Acquisition Corp IICNDA · Entity 6850 | Director | August 31, 2021 | September 01, 2021 |
| GCT Semiconductor Holding, Inc.CNDB · Entity 6473 | Director | November 16, 2023 | November 17, 2023 |
| Hyperliquid Strategies IncPURR · Entity 681 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Concord Acquisition Corp
Report date December 07, 2020 · Filed December 08, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2020-12-07 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-249654). |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-249654).
Concord Acquisition Corp II
Report date August 31, 2021 · Filed September 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-08-31 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-254788). |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-254788).
GCT Semiconductor Holding, Inc.
Report date November 16, 2023 · Filed November 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 30,000 |
Reported balance
After 2023-11-16 transaction · row 1
1 source rowRow 1 · 2023-11-16 · Conversion · Acquired 30,000 · Balance 30,000 F1: Represents shares of Class A common stock of the Issuer acquired upon conversion of shares of Class B common stock of the Issuer at the Reporting Person's election. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-11-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-11-16 · Conversion · Disposed 30,000 · Balance 0 F2: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-254789). F1: Represents shares of Class A common stock of the Issuer acquired upon conversion of shares of Class B common stock of the Issuer at the Reporting Person's election. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A common stock of the Issuer acquired upon conversion of shares of Class B common stock of the Issuer at the Reporting Person's election.
F2: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-254789).
Hyperliquid Strategies Inc
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,980 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 2,117 · Balance 85,980 F1: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
COWEN INC.
Report date March 01, 2023 · Filed March 01, 2023
Section 16 reporting ended · disclosed 2023-03-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2023-03-01 · Disposition to issuer · Disposed 8,000 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of August 1, 2022 (the "Merger Agreement"), by and among The Toronto-Dominion Bank, a Canadian chartered bank ("Parent"), Crimson Holdings Acquisition Co., a Delaware corporation ("Merger Sub") and an indirect wholly owned subsidiary of Parent and Cowen Inc., a Delaware corporation (the "Company"), on March 1, 2023 (the "Effective Time"), Merger Sub merged with and into the Company with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). F2: At the Effective Time, each share of Class A common stock, par value $0.01 per share, of the Company ("Class A Company Common Stock") issued and outstanding immediately prior to the Effective Time and each share of Class B common stock, par value $0.01 per share, of the Company (together with Class A Company Common Stock, "Company Common Stock") issued and outstanding immediately prior to the Effective Time (except for (i) shares of Company Common Stock owned by the Company or Parent (in each case, other than shares of Company Common Stock (A) held in trust accounts, managed accounts, mutual funds and the like, or otherwise held in a fiduciary or agency capacity, or (B) held, directly or indirectly, in respect of a debt previously contracted) and (ii) any shares of Company Common Stock with respect to which dissenters' rights have been exercised) was automatically canceled and converted into the right to receive $39.00 in cash, without interest (the "Merger Consideration"). |
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2023-03-01 · Disposition to issuer · Disposed 42,098 · Balance 0 F3: This line item represents outstanding restricted stock units held by the Reporting Person. Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit held by a current or former non-employee director of the Company ("Director RSU") (whether settled or unsettled) immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the number of shares of Company Common Stock subject to such Director RSU immediately prior to the Effective Time and (ii) the Merger Consideration. F4: With respect to any Director RSUs that constitute nonqualified deferred compensation subject to Section 409A of the Internal Revenue Code of 1986, as amended (the "Code") and that are not permitted to be paid at the Effective Time without triggering a Tax (as defined in the Merger Agreement) or penalty under Section 409A of the Code, the payment referenced under point 3 above shall be made at the earliest time permitted under the applicable Stock Plan (as defined in the Merger Agreement) and award agreement that will not trigger a Tax or penalty under Section 409A of the Code. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of August 1, 2022 (the "Merger Agreement"), by and among The Toronto-Dominion Bank, a Canadian chartered bank ("Parent"), Crimson Holdings Acquisition Co., a Delaware corporation ("Merger Sub") and an indirect wholly owned subsidiary of Parent and Cowen Inc., a Delaware corporation (the "Company"), on March 1, 2023 (the "Effective Time"), Merger Sub merged with and into the Company with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger").
F2: At the Effective Time, each share of Class A common stock, par value $0.01 per share, of the Company ("Class A Company Common Stock") issued and outstanding immediately prior to the Effective Time and each share of Class B common stock, par value $0.01 per share, of the Company (together with Class A Company Common Stock, "Company Common Stock") issued and outstanding immediately prior to the Effective Time (except for (i) shares of Company Common Stock owned by the Company or Parent (in each case, other than shares of Company Common Stock (A) held in trust accounts, managed accounts, mutual funds and the like, or otherwise held in a fiduciary or agency capacity, or (B) held, directly or indirectly, in respect of a debt previously contracted) and (ii) any shares of Company Common Stock with respect to which dissenters' rights have been exercised) was automatically canceled and converted into the right to receive $39.00 in cash, without interest (the "Merger Consideration").
F3: This line item represents outstanding restricted stock units held by the Reporting Person. Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit held by a current or former non-employee director of the Company ("Director RSU") (whether settled or unsettled) immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the number of shares of Company Common Stock subject to such Director RSU immediately prior to the Effective Time and (ii) the Merger Consideration.
F4: With respect to any Director RSUs that constitute nonqualified deferred compensation subject to Section 409A of the Internal Revenue Code of 1986, as amended (the "Code") and that are not permitted to be paid at the Effective Time without triggering a Tax (as defined in the Merger Agreement) or penalty under Section 409A of the Code, the payment referenced under point 3 above shall be made at the earliest time permitted under the applicable Stock Plan (as defined in the Merger Agreement) and award agreement that will not trigger a Tax or penalty under Section 409A of the Code.
Enfusion, Inc.
Report date April 21, 2025 · Filed April 21, 2025
Section 16 reporting ended · disclosed 2025-04-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-04-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-04-21 · Disposition to issuer · Disposed 175,572 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock"), issued and outstanding was converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F3: Represents shares of Common Stock and shares underlying restricted stock units of Enfusion, which were converted into the right to receive the merger consideration, at the election of the holder of such share of Common Stock. F4: As a result of the consummation of the transactions contemplated Merger Agreement, the Reporting Person ceased to be the beneficial owner of any securities of Enfusion. This Form 4 constitutes an exit filing by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion.
F2: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock"), issued and outstanding was converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration").
F3: Represents shares of Common Stock and shares underlying restricted stock units of Enfusion, which were converted into the right to receive the merger consideration, at the election of the holder of such share of Common Stock.
F4: As a result of the consummation of the transactions contemplated Merger Agreement, the Reporting Person ceased to be the beneficial owner of any securities of Enfusion. This Form 4 constitutes an exit filing by the Reporting Person.
Forge Global Holdings, Inc.
Report date March 02, 2026 · Filed March 04, 2026
Section 16 reporting ended · disclosed 2026-03-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-03-02 transaction · row 1
1 source rowRow 1 · 2026-03-02 · Disposition to issuer · Disposed 27,588 · Balance 0 F1: Reflects the disposition of shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer, or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 5, 2025 (the "Merger Agreement"), by and among the Issuer, The Charles Schwab Corporation ("Parent") and Ember-Falcon Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, on March 2, 2026, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). F2: Pursuant to the Merger Agreement, at the Effective Time, each issued and outstanding share of Common Stock (other than certain excluded shares described in the Merger Agreement) was cancelled and converted automatically into the right to receive cash (without interest) in an amount equal to $45.00 per share of Common Stock (the "Merger Consideration"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-02 · Disposition to issuer · Disposed 5,668 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit (each, a "Company RSU") was assumed and converted into a restricted stock unit award of Parent, ("Parent RSU") covering a number of shares of common stock of Parent par value $0.01 per share ("Parent Common Stock") equal to the product of (i) the number of shares of Common Stock then subject to such Company RSU immediately prior to the Effective Time, multiplied by (ii) the quotient of the Merger Consideration, divided by $94.7880, which is the average, rounded to the nearest one ten-thousandth, of the closing-sale prices of shares of Parent Common Stock on the New York Stock Exchange as reported by The Wall Street Journal for the five full trading days ending on (and including) the trading day preceding the Closing Date (the "Equity Award Exchange Ratio"). F1: Reflects the disposition of shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer, or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 5, 2025 (the "Merger Agreement"), by and among the Issuer, The Charles Schwab Corporation ("Parent") and Ember-Falcon Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, on March 2, 2026, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer, or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 5, 2025 (the "Merger Agreement"), by and among the Issuer, The Charles Schwab Corporation ("Parent") and Ember-Falcon Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, on March 2, 2026, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger").
F2: Pursuant to the Merger Agreement, at the Effective Time, each issued and outstanding share of Common Stock (other than certain excluded shares described in the Merger Agreement) was cancelled and converted automatically into the right to receive cash (without interest) in an amount equal to $45.00 per share of Common Stock (the "Merger Consideration").
F3: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit (each, a "Company RSU") was assumed and converted into a restricted stock unit award of Parent, ("Parent RSU") covering a number of shares of common stock of Parent par value $0.01 per share ("Parent Common Stock") equal to the product of (i) the number of shares of Common Stock then subject to such Company RSU immediately prior to the Effective Time, multiplied by (ii) the quotient of the Merger Consideration, divided by $94.7880, which is the average, rounded to the nearest one ten-thousandth, of the closing-sale prices of shares of Parent Common Stock on the New York Stock Exchange as reported by The Wall Street Journal for the five full trading days ending on (and including) the trading day preceding the Closing Date (the "Equity Award Exchange Ratio").
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 6, 2026 20:52 UTC | Hyperliquid Strategies Inc PURR · Entity 681 | GrantCommon Stock | 2,117 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-296316 · ownership.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,980 F1 · price: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 18:53 UTC | Hyperliquid Strategies Inc PURR · Entity 681 | GrantCommon Stock | 3,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-139796 · ownership.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,863 F1 · price: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. F1 · acquired: Represents restricted shares of common stock the reporting person elected to receive as compensation in lieu of cash pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 02:32 UTC | Forge Global Holdings, Inc. FRGE · Entity 63107 | Disposition to issuerRestricted Stock Units · Derivative | 5,668 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001276505-26-000001 · wk-form4_1772591544.xml · derivative · entry 2 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value per share · 5,668 shares Expires not disclosed F3 · derivative.exercise_price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit (each, a "Company RSU") was assumed and converted into a restricted stock unit award of Parent, ("Parent RSU") covering a number of shares of common stock of Parent par value $0.01 per share ("Parent Common Stock") equal to the product of (i) the number of shares of Common Stock then subject to such Company RSU immediately prior to the Effective Time, multiplied by (ii) the quotient of the Merger Consideration, divided by $94.7880, which is the average, rounded to the nearest one ten-thousandth, of the closing-sale prices of shares of Parent Common Stock on the New York Stock Exchange as reported by The Wall Street Journal for the five full trading days ending on (and including) the trading day preceding the Closing Date (the "Equity Award Exchange Ratio"). F1 · kind: Reflects the disposition of shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer, or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 5, 2025 (the "Merger Agreement"), by and among the Issuer, The Charles Schwab Corporation ("Parent") and Ember-Falcon Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, on March 2, 2026, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit (each, a "Company RSU") was assumed and converted into a restricted stock unit award of Parent, ("Parent RSU") covering a number of shares of common stock of Parent par value $0.01 per share ("Parent Common Stock") equal to the product of (i) the number of shares of Common Stock then subject to such Company RSU immediately prior to the Effective Time, multiplied by (ii) the quotient of the Merger Consideration, divided by $94.7880, which is the average, rounded to the nearest one ten-thousandth, of the closing-sale prices of shares of Parent Common Stock on the New York Stock Exchange as reported by The Wall Street Journal for the five full trading days ending on (and including) the trading day preceding the Closing Date (the "Equity Award Exchange Ratio"). F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit (each, a "Company RSU") was assumed and converted into a restricted stock unit award of Parent, ("Parent RSU") covering a number of shares of common stock of Parent par value $0.01 per share ("Parent Common Stock") equal to the product of (i) the number of shares of Common Stock then subject to such Company RSU immediately prior to the Effective Time, multiplied by (ii) the quotient of the Merger Consideration, divided by $94.7880, which is the average, rounded to the nearest one ten-thousandth, of the closing-sale prices of shares of Parent Common Stock on the New York Stock Exchange as reported by The Wall Street Journal for the five full trading days ending on (and including) the trading day preceding the Closing Date (the "Equity Award Exchange Ratio"). F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit (each, a "Company RSU") was assumed and converted into a restricted stock unit award of Parent, ("Parent RSU") covering a number of shares of common stock of Parent par value $0.01 per share ("Parent Common Stock") equal to the product of (i) the number of shares of Common Stock then subject to such Company RSU immediately prior to the Effective Time, multiplied by (ii) the quotient of the Merger Consideration, divided by $94.7880, which is the average, rounded to the nearest one ten-thousandth, of the closing-sale prices of shares of Parent Common Stock on the New York Stock Exchange as reported by The Wall Street Journal for the five full trading days ending on (and including) the trading day preceding the Closing Date (the "Equity Award Exchange Ratio"). Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 02:32 UTC | Forge Global Holdings, Inc. FRGE · Entity 63107 | Disposition to issuerCommon Stock, $0.0001 par value per share | 27,588 | $45.00 | $1,241,460.00 |
DisclosureSEC source: 0001276505-26-000001 · wk-form4_1772591544.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects the disposition of shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer, or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 5, 2025 (the "Merger Agreement"), by and among the Issuer, The Charles Schwab Corporation ("Parent") and Ember-Falcon Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, on March 2, 2026, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). F1 · shares: Reflects the disposition of shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer, or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 5, 2025 (the "Merger Agreement"), by and among the Issuer, The Charles Schwab Corporation ("Parent") and Ember-Falcon Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, on March 2, 2026, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). F1 · price: Reflects the disposition of shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer, or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 5, 2025 (the "Merger Agreement"), by and among the Issuer, The Charles Schwab Corporation ("Parent") and Ember-Falcon Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, on March 2, 2026, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each issued and outstanding share of Common Stock (other than certain excluded shares described in the Merger Agreement) was cancelled and converted automatically into the right to receive cash (without interest) in an amount equal to $45.00 per share of Common Stock (the "Merger Consideration"). Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:33 UTC | Hyperliquid Strategies Inc PURR · Entity 681 | GrantCommon Stock | 40,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047179 · ownership.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,589 F1 · price: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. F1 · acquired: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028. Read SEC document |
| December 04, 2025 Filed Dec 12, 2025 16:55 UTC | Hyperliquid Strategies Inc PURR · Entity 681 | OtherCommon Stock | 39,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-317202 · ownership.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,800 F1 · price: On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 39,800 shares of Common Stock to Mr. Leibowitz, a member of Rorschach Capital LLC. Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 19:42 UTC | Forge Global Holdings, Inc. FRGE · Entity 63107 | GrantCommon Stock, $0.0001 par value per share | 6,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-035549 · wk-form4_1753213342.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,256 F1 · shares: These shares represent restricted stock units granted under the Forge Global Holdings, Inc. 2022 Stock Option and Incentive Plan (the "Plan"). Each unit represents a right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continued Service Relationship (as defined in the Plan) through each applicable vesting date, 4/12th of the award shall vest on the Vesting Commencement Date and the remaining 8/12th of the award shall vest in equal monthly installments on the last day of each month thereafter. Vested RSUs shall settle on the nearest Monthly Settlement Date following the applicable vesting date or as soon as practicable following such applicable vesting date. Monthly Settlement Dates are defined as on or about the 10th day of each month. Read SEC document |
| June 20, 2025 Filed Jun 25, 2025 00:51 UTC | Forge Global Holdings, Inc. FRGE · Entity 63107 | GrantCommon Stock, $0.0001 par value per share | 11,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032951 · wk-form4_1750812687.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,183 F1 · shares: These shares represent restricted stock units granted under the Forge Global Holdings, Inc. 2022 Stock Option and Incentive Plan (the "Plan"). Each unit represents a right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continued Service Relationship (as defined in the Plan) through each applicable vesting date, 1/4th of the shares subject to the award shall vest and settle on the first Quarterly Vesting Date occurring after the grant date and each Quarterly Vesting Date thereafter, or as soon as practicable following such applicable vesting date. Quarterly Vesting Dates are defined as March 1, June 1, September 1, and December 1 of a given year. F2 · balance_after: On April 14, 2025, the Issuer effected a 1-for-15 reverse split of the Issuer's common stock, resulting in proportionate adjustments to the number of shares of common stock beneficially owned by the Reporting Person. Accordingly, the securities reported on this Form 4 have been adjusted to reflect the reverse stock split. Read SEC document |
| April 21, 2025 Filed Apr 21, 2025 17:09 UTC | Enfusion, Inc. ENFN · Entity 80590 | Disposition to issuerClass A Common Stock | 175,572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-036905 · tm2512604-7_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2 · kind: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock"), issued and outstanding was converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F3 · shares: Represents shares of Common Stock and shares underlying restricted stock units of Enfusion, which were converted into the right to receive the merger consideration, at the election of the holder of such share of Common Stock. F2 · price: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock"), issued and outstanding was converted into the right to receive, at the election of the holder of such share of Common Stock, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F3 · price: Represents shares of Common Stock and shares underlying restricted stock units of Enfusion, which were converted into the right to receive the merger consideration, at the election of the holder of such share of Common Stock. F4 · balance_after: As a result of the consummation of the transactions contemplated Merger Agreement, the Reporting Person ceased to be the beneficial owner of any securities of Enfusion. This Form 4 constitutes an exit filing by the Reporting Person. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 21:08 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 13,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-072468 · tm2417466-4_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,572 F1 · shares: Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The RSUs will vest in full on the earlier of June 13, 2025, or the date of the 2025 annual meeting of stockholders of the issuer. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 23:12 UTC | Forge Global Holdings, Inc. FRGE · Entity 63107 | GrantCommon Stock, $0.0001 par value per share | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-028126 · wk-form4_1718320354.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,760 F1 · shares: These shares represent restricted stock units granted under the Forge Global Holdings, Inc. 2022 Stock Option and Incentive Plan (the "Plan"). Each unit represents a right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continued Service Relationship (as defined in the Plan) through each applicable vesting date, 1/4th of the shares subject to the award shall vest and settle on the first Quarterly Vesting Date occurring after the grant date and each Quarterly Vesting Date thereafter, or as soon as practicable following such applicable vesting date. Quarterly Vesting Dates are defined as March 1, June 1, September 1, and December 1 of a given year. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:51 UTC | Forge Global Holdings, Inc. FRGE · Entity 63107 | GrantCommon Stock, $0.0001 par value per share | 127,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-010708 · wk-form4_1710287496.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,760 F1 · shares: These shares represent restricted stock units granted under the Forge Global Holdings, Inc. 2022 Stock Option and Incentive Plan (the "Plan"). Each unit represents a right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person's continued Service Relationship (as defined in the Plan) through each applicable vesting date, 1/12th of the shares subject to the award shall vest and settle beginning on the first Quarterly Vesting Date occurring after the date the Reporting Person's service as a non-employee member of the Board of Directors of the Issuer commenced and each Quarterly Vesting Date thereafter, or as soon as practicable following such applicable vesting date. Quarterly Vesting Dates are defined as March 1, June 1, September 1, and December 1 of a given year. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 23:02 UTC | GCT Semiconductor Holding, Inc. CNDB · Entity 6473 | ConversionClass B Common Stock · Derivative | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-119629 · tm2331046-2_4seq1.xml · derivative · entry 2 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-254789). F1 · kind: Represents shares of Class A common stock of the Issuer acquired upon conversion of shares of Class B common stock of the Issuer at the Reporting Person's election. F1 · price: Represents shares of Class A common stock of the Issuer acquired upon conversion of shares of Class B common stock of the Issuer at the Reporting Person's election. F2 · derivative.exercise_date: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-254789). F2 · derivative.expiration_date: The shares of Class B common stock have no expiration date and will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-254789). Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 23:02 UTC | GCT Semiconductor Holding, Inc. CNDB · Entity 6473 | ConversionClass A Common Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-119629 · tm2331046-2_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of Class A common stock of the Issuer acquired upon conversion of shares of Class B common stock of the Issuer at the Reporting Person's election. F1 · price: Represents shares of Class A common stock of the Issuer acquired upon conversion of shares of Class B common stock of the Issuer at the Reporting Person's election. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 16:15 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 6,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-093500 · tm2324148-1_4seq1.xml · nonDerivative · entry 2 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,102 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 16:15 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 10,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-093500 · tm2324148-1_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,767 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 20:27 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 1,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-092107 · tm2323724-6_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,414 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 17:13 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 1,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-091506 · tm2323724-3_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,082 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 16:15 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 1,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-090488 · tm2323526-3_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,616 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 18:48 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 1,733 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-089936 · tm2323475-1_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,017 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 16:15 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 15,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-075805 · tm2319824-1_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,284 F1 · shares: Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The RSUs will vest in full on the earlier of June 16, 2024, or the date of the 2024 annual meeting of stockholders of the issuer. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:28 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 14,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-072916 · tm2319225-4_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,051 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares"). Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:16 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 37,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-065474 · tm2317169-2_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,473 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares"). Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 16:15 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 7,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-051352 · tm2313987-1_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,077 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares"). Read SEC document |
| March 01, 2023 Filed Mar 1, 2023 11:41 UTC | COWEN INC. COWN · Entity 89620 | Disposition to issuerClass A Common Stock | 42,098 | $39.00 | $1,641,822.00 |
DisclosureSEC source: 0001415889-23-003613 · form4-03012023_040315.xml · nonDerivative · entry 2 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: This line item represents outstanding restricted stock units held by the Reporting Person. Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit held by a current or former non-employee director of the Company ("Director RSU") (whether settled or unsettled) immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the number of shares of Company Common Stock subject to such Director RSU immediately prior to the Effective Time and (ii) the Merger Consideration. F4 · price: With respect to any Director RSUs that constitute nonqualified deferred compensation subject to Section 409A of the Internal Revenue Code of 1986, as amended (the "Code") and that are not permitted to be paid at the Effective Time without triggering a Tax (as defined in the Merger Agreement) or penalty under Section 409A of the Code, the payment referenced under point 3 above shall be made at the earliest time permitted under the applicable Stock Plan (as defined in the Merger Agreement) and award agreement that will not trigger a Tax or penalty under Section 409A of the Code. Read SEC document |
| March 01, 2023 Filed Mar 1, 2023 11:41 UTC | COWEN INC. COWN · Entity 89620 | Disposition to issuerClass A Common Stock | 8,000 | $39.00 | $312,000.00 |
DisclosureSEC source: 0001415889-23-003613 · form4-03012023_040315.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of August 1, 2022 (the "Merger Agreement"), by and among The Toronto-Dominion Bank, a Canadian chartered bank ("Parent"), Crimson Holdings Acquisition Co., a Delaware corporation ("Merger Sub") and an indirect wholly owned subsidiary of Parent and Cowen Inc., a Delaware corporation (the "Company"), on March 1, 2023 (the "Effective Time"), Merger Sub merged with and into the Company with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). F2 · price: At the Effective Time, each share of Class A common stock, par value $0.01 per share, of the Company ("Class A Company Common Stock") issued and outstanding immediately prior to the Effective Time and each share of Class B common stock, par value $0.01 per share, of the Company (together with Class A Company Common Stock, "Company Common Stock") issued and outstanding immediately prior to the Effective Time (except for (i) shares of Company Common Stock owned by the Company or Parent (in each case, other than shares of Company Common Stock (A) held in trust accounts, managed accounts, mutual funds and the like, or otherwise held in a fiduciary or agency capacity, or (B) held, directly or indirectly, in respect of a debt previously contracted) and (ii) any shares of Company Common Stock with respect to which dissenters' rights have been exercised) was automatically canceled and converted into the right to receive $39.00 in cash, without interest (the "Merger Consideration"). Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 19:15 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 7,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-007628 · tm234681-2_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,839 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares"). Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 21:20 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 7,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-112112 · tm2229129-2_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,601 F1 · shares: Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares"). Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 16:22 UTC | COWEN INC. COWN · Entity 89620 | GrantClass A Common Stock | 7,672 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-009220 · form4-09012022_010948.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,961 F1 · price: Grant of restricted stock units for no monetary consideration. The shares underlying the restricted stock units will be delivered in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:33 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 12,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-072529 · tm2218834-3_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,362 F1 · shares: Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units will vest in full on the earlier of June 16, 2023, or the date of the 2023 annual meeting of stockholders of the issuer. Read SEC document |
| October 31, 2021 Filed Nov 2, 2021 18:10 UTC | Enfusion, Inc. ENFN · Entity 80590 | GrantClass A Common Stock | 5,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-133215 · tm2131338-3_4seq1.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,684 F1 · shares: Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units will vest in full on the date of the 2022 annual meeting of stockholders of the issuer. Read SEC document |
| October 27, 2021 Filed Oct 29, 2021 17:00 UTC | COWEN INC. COWN · Entity 89620 | GrantClass A Common Stock | 4,720 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009714 · edgar.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,289 F1 · price: Grant of restricted stock units for no monetary consideration. The shares underlying the restricted stock units will be delivered in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 16:58 UTC | COWEN INC. COWN · Entity 89620 | GrantClass A Common Stock | 10,965 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-008523 · edgar.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,569 F1 · price: Grant of restricted stock units for no monetary consideration. The shares underlying the restricted stock units will be delivered in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 07:56 UTC | COWEN INC. COWN · Entity 89620 | PurchaseClass A Common Stock | 8,000 | $12.13 | $97,044.00 |
DisclosureSEC source: 0001179110-20-003444 · edgar.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,604 Read SEC document |
| July 24, 2019 Filed Jul 25, 2019 16:14 UTC | COWEN INC. COWN · Entity 89620 | GrantClass A Common Stock | 9,355 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-008814 · edgar.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,604 F1 · price: Grant of restricted stock units for no monetary consideration. The shares underlying the restricted stock units will be delivered in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 16:57 UTC | COWEN INC. COWN · Entity 89620 | GrantClass A Common Stock | 9,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-010147 · edgar.xml · nonDerivative · entry 1 LEIBOWITZ LAWRENCE E · CIK 0001276505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,249 F1 · price: Grant of restricted stock units for no monetary consideration. The shares underlying the restricted stock units will be delivered in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.